Arbutus Biopharma Corp (ABUS)

Income Before Tax

-$5.14M

Quarterly · Period ending: · USD

ABUS logo

ABUS Income Before Tax

Latest reported-$5.14M
ABUS Quarterly Pre-Tax Income (-$4.82M → -$5.14M)
High-resolution chart · PNG

ABUS income before tax history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Arbutus Biopharma Corp Income Before Tax — Quarterly (USD)
Period endingIncome Before Tax (USD)
-5,143,000
169,695,000
-3,756,000
-7,742,000
2,523,000
-24,526,000
-12,532,000
-19,717,000
-19,796,000
-17,875,000
-19,312,000
-20,104,000
-17,094,000
-16,339,000
-21,932,000
-17,567,000
-14,192,000
-11,321,000
-21,321,000
-19,158,000
-19,387,000
-16,381,000
-17,042,000
-18,755,000
-14,087,000
-13,861,000
-24,654,000
-95,159,000
-23,315,000
-23,251,000
-18,249,000
-28,755,000
3,091,000
-17,429,000
-60,251,000
-11,600,000
-18,255,000
-18,627,000
-258,833,000
-19,595,000
-194,864,000
-15,874,000
-6,253,000
-44,178,000
-14,900,000
-11,989,000
-6,168,000
-8,604,000
-6,081,000
-17,984,000
-2,615,640
-5,896,390
-2,951,185
-2,577,439
29,793,048,000,000
-3,516,456
-1,919,851
-3,191,400
-9,937,000,000
-1,432,983
-3,676,809
-3,221,457
2,600,549
-2,600,550
-4,019,454
-4,354,347
-2,660,892
-2,666,445
-1,965,415
-1,709,964
-1,045,549
-5,688,681
-4,757,340
-633,595
357,853
1,515,510
-4,824,240
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.